The elimination of malignant B lymphocytes from human bone marrow using monoclonal antibodies DLC-48 and LN-1 and human serum: A preclinical study

Monoclonal antibody DLC-48: An effective

Monoclonal antibody DLC-48: An effective reagent for use in the depletion of malignant lymphoma from human bone marrow

✍ Jane N. Winter; Robert J. Marder; James A. Radosevich; Alan L. Epstein 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 French ⚖ 891 KB

A combination of large-cell lymphoma cell lines was used as immunogen in the production of DLC-48, a mouse monoclonal antibody (MAb) to a B-cell-associated antigen. This reagent identifies a protein found on a majority of peripheral blood B-cells, B-cell derived tumor cell lines, and lymphoma biopsy